Literature DB >> 17551371

What is new in vitamin D: 2006-2007.

Daniel D Bikle1.   

Abstract

PURPOSE OF REVIEW: This review focuses on recent developments in a number of areas to bring the reader up to the current state of knowledge in this field. RECENT
FINDINGS: A number of studies have revealed new insights into the regulation of the vitamin D receptor and new targets for its action. The mechanism by which a number of drugs can reduce circulating 25OHD has been clarified. New drug targets including increased bone by inhibition of osteoclasts, improvement in diabetes mellitus, and stimulation of innate immunity to combat infections such as tuberculosis have been found.
SUMMARY: The wide distribution of the vitamin D receptor provides a number of clinical targets for vitamin D and its analogs. The wide distribution of CYP27B1, the enzyme required to convert circulating 25OHD to 1,25(OH)2D enables a number of cells to make their own 1,25(OH)2D3 if circulating 25OHD levels are maintained. These newer studies emphasize that vitamin D is not just for bones, and maintaining adequate levels is important for many tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17551371     DOI: 10.1097/BOR.0b013e32818e9d58

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  26 in total

1.  Impact of vitamin D3 on cutaneous immunity and antimicrobial peptide expression.

Authors:  Attila S Antal; Yvonne Dombrowski; Sarah Koglin; Thomas Ruzicka; Jürgen Schauber
Journal:  Dermatoendocrinol       Date:  2011-01

Review 2.  Antimicrobial peptides and the skin immune defense system.

Authors:  Jürgen Schauber; Richard L Gallo
Journal:  J Allergy Clin Immunol       Date:  2008-04-25       Impact factor: 10.793

3.  A new steroidal 5,7-diene derivative, 3beta-hydroxyandrosta-5,7-diene-17beta-carboxylic acid, shows potent anti-proliferative activity.

Authors:  Tae-Kang Kim; Jianjun Chen; Wei Li; Jordan Zjawiony; Duane Miller; Zorica Janjetovic; Robert C Tuckey; Andrzej Slominski
Journal:  Steroids       Date:  2009-12-16       Impact factor: 2.668

4.  Neglected tropical diseases and vitamin B12: a review of the current evidence.

Authors:  Alexander J Layden; Kristos Täse; Julia L Finkelstein
Journal:  Trans R Soc Trop Med Hyg       Date:  2018-10-01       Impact factor: 2.184

Review 5.  Eldecalcitol: a review of its use in the treatment of osteoporosis.

Authors:  Mark Sanford; Paul L McCormack
Journal:  Drugs       Date:  2011-09-10       Impact factor: 9.546

Review 6.  Vitamin D insufficiency and insulin resistance in obese adolescents.

Authors:  Catherine A Peterson; Aneesh K Tosh; Anthony M Belenchia
Journal:  Ther Adv Endocrinol Metab       Date:  2014-12       Impact factor: 3.565

Review 7.  Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?

Authors:  James B Wetmore; L Darryl Quarles
Journal:  Nat Clin Pract Nephrol       Date:  2008-10-28

8.  Products of vitamin D3 or 7-dehydrocholesterol metabolism by cytochrome P450scc show anti-leukemia effects, having low or absent calcemic activity.

Authors:  Andrzej T Slominski; Zorica Janjetovic; Brian E Fuller; Michal A Zmijewski; Robert C Tuckey; Minh N Nguyen; Trevor Sweatman; Wei Li; Jordan Zjawiony; Duane Miller; Tai C Chen; Gerard Lozanski; Michael F Holick
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

Review 9.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871

Review 10.  The vitamin D pathway: a new target for control of the skin's immune response?

Authors:  Jürgen Schauber; Richard L Gallo
Journal:  Exp Dermatol       Date:  2008-06-28       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.